Calcium AKG: Aging Claims, Human Evidence and Calcium Content

What is calcium AKG?

Calcium AKG contains alpha-ketoglutarate, a molecule your cells make while turning food into energy. The alpha-ketoglutarate is bound to calcium to make a stable powder or tablet.

People take it hoping to slow aging, lower a “biological age” test result, or support muscle and collagen. Human research includes a small controlled bone study as well as aging reports. The bone study found a change in a bone-breakdown marker without a significant bone-density advantage; it did not test longevity. Whether calcium AKG slows human aging remains open.

You make alpha-ketoglutarate yourself, so it is not a vitamin or an essential nutrient, and food is not a meaningful source. The alpha-ketoglutarate your body makes helps enzymes involved in collagen production and in removing chemical tags from DNA. These roles explain researchers' interest in the supplement. Retail calcium AKG is a manufactured supplement ingredient.

The published customer report and the still-unreported placebo trial used 1 g of calcium AKG a day, often as two 500 mg tablets in a timed- or sustained-release form. That gram carries about 190 mg of calcium.

What is the difference between calcium AKG and a calcium supplement?

A calcium supplement is sold to supply calcium: a calcium carbonate or citrate tablet usually lists hundreds of milligrams of calcium, toward the 1,000 to 1,200 mg adults need. Calcium AKG is sold for the alpha-ketoglutarate, and the calcium is only the part that holds it together, about 190 mg per gram. If your goal is meeting a calcium requirement, compare the declared calcium amount and serving size with ordinary calcium products; the AKG weight is not the calcium amount. If your goal is similar to the aging experiment, the calcium is a side number to count toward your total calcium intake.

What alpha-ketoglutarate does in your body

Alpha-ketoglutarate is an intermediate in the citric acid cycle, a sequence of reactions that helps cells extract energy from food. It is produced and then used again as the cycle continues, linking it to the supply of other small molecules used in metabolism.

It also participates in handling amino acids and nitrogen. Cells can convert alpha-ketoglutarate into glutamate and use related reactions to move nitrogen between molecules. Certain enzymes also use alpha-ketoglutarate while modifying proteins or regulating gene activity.

Calcium AKG is a manufactured salt supplying calcium and alpha-ketoglutarate. Its effects as a supplement are being tested separately from the molecule's established cellular roles. ^[1]

The short version

Unit: milligrams of calcium AKG. The calcium it carries is a separate, smaller number on the label.

Evidence amount: a customer report and the pending placebo trial used 1 g a day. No completed placebo result cited here establishes an anti-aging benefit, and long-term safety at 1 to 2 g a day remains uncertain.

Typical listings: 500 mg to 1 g of calcium AKG per serving, about 190 mg of calcium per gram.

Label check: count the actual calcium amount. Claims of fracture prevention, reversing aging by years, or building muscle need outcome-specific support; the bone-marker trial does not establish those benefits.

What people take calcium AKG for

Calcium AKG has no recommended amount and is not a practical primary calcium supplement: a 1 g serving carries about 190 mg, a fraction of the 1,000 to 1,200 mg adults need each day. People take it mainly as an aging experiment. That claim rests on animal studies and uncontrolled human reports; the separate controlled bone trial answers a different question.

When to ask a doctor before taking calcium AKG

Ask first if you take a medicine that must be kept apart from calcium, such as some osteoporosis or thyroid drugs, because the calcium in the product counts. Ask too if a doctor has told you to limit calcium, or if you already take calcium tablets. No rule exists for how far apart to take AKG itself from medicines, and long-term safety at 1 to 2 g a day has not been studied.

Common dosage

As of 2026, there is no recognized recommended daily amount for calcium AKG. We checked the National Institutes of Health Office of Dietary Supplements and the National Academies, which set official nutrient amounts; neither has set one for AKG, or an upper limit. The amount people take, 1 g of calcium AKG a day, comes from the human aging studies, not from any agency. It is not set by sex, body weight, or age.

The calcium is a different matter. The recommended daily amount for calcium from the National Academies is 1,000 to 1,200 mg for adults. The official upper limit is 2,500 mg a day from all sources at ages 19 to 50, and 2,000 mg from age 51. The 190 mg in a 1 g serving counts toward both numbers.

What you can buy

Calcium AKG is sold as a single ingredient or in branded formulas, and the table shows how the common listings differ. No study has compared these forms with each other.

Can you take calcium AKG with another calcium product the same day?

The calcium is the part with a known limit. The official upper limit for calcium is 2,500 mg a day from all sources at 19 to 50 and 2,000 mg from 51. A 1 g serving adds about 190 mg, which matters if you also take calcium tablets and eat a lot of dairy.

The uncontrolled 2021 customer report used a timed-release 1 g product with added vitamins, and the unfinished placebo trial uses 1 g in sustained-release tablets. Count the calcium, and count any added vitamin toward your total for that vitamin.

What to pay attention to on the label

The number that counts is milligrams of calcium AKG, and the second number to find is the calcium it carries.

Which number on the label is the amount?

A calcium AKG label usually lists two lines: the calcium AKG itself, such as 1,000 mg, and calcium, such as 190 mg. The first is the experimental dose. The second is the calcium you are getting, and it is what counts toward your calcium total.

Misleading labels

Filed with calcium or bone supplements

Some shops list calcium AKG with calcium products, and some labels mention bones. A gram of the calcium AKG formulation discussed here gives about 190 mg of calcium, a fifth or less of the daily amount. A controlled bone study did test calcium AKG, but at a much larger regimen with matched calcium in the comparison group. Its marker finding did not establish improved bone density or fracture prevention.

Confusing servings and items per serving

Some manufacturers put 180 tablets on the front, and the back says 2 tablets per serving and 90 servings. The calcium AKG on the Supplement Facts panel is for the whole 2-tablet serving.

“Reverses aging by years”

Some labels and ads promise a biological age years younger. That claim traces to a 2021 study of 42 customers with no placebo group, measured on a company’s own saliva test. Broader “longevity” claims also borrow from a 2020 mouse study in which calcium AKG extended lifespan, mainly in females. Neither result is a controlled longevity trial in people.

Muscle and collagen

Some labels say calcium AKG builds muscle or collagen. Alpha-ketoglutarate helps collagen-building enzymes in the body, but no placebo-controlled trial has tested a calcium AKG supplement for muscle or collagen in people.

“Cellular energy”

Alpha-ketoglutarate participates in the body's energy cycle. A label can describe that role, but it does not show that taking calcium AKG raises your energy. The customer study mentioned above also does not turn a “clinically studied” label into evidence of an energy benefit.

How calcium AKG interacts with other nutrients

Vitamin D is the nutrient most often sold with calcium AKG. No interaction between them has been tested.

Vitamin D

Some products combine calcium AKG with vitamin D (and some with vitamin A), and the pairing can look like a calcium-and-vitamin-D bone supplement. The label still needs to distinguish calcium from AKG. A bone-marker trial has been done with calcium AKG, but it did not test whether adding vitamin D to a retail aging formula improves bone outcomes. In the 2021 customer study, women took vitamin D and men took vitamin A in the same tablet, so any change in their results cannot be credited to AKG alone. If you need vitamin D, take it for its own reason and at its own recommended amount.

Common Myths about Calcium AKG

Is calcium AKG a good calcium supplement?

No. A gram gives about 190 mg of calcium. Reaching the 1,000 mg adult amount would take more than 5 g of calcium AKG, several times what any study used, and a regular calcium carbonate or citrate tablet does that job directly.

Did calcium AKG make people 8 years younger?

Not in a controlled test. The 42 customers in that 2021 study had no placebo group, took the product with added vitamins, and were measured on a clock that was already off by about 4 years for a typical person. A later study of 4,260 test buyers found a favorable one-time association, but its repeat-test results did not remain clearly favorable after the fullest adjustment. Healthier people choosing the product could help explain the one-time difference.

Does it extend life because it worked in mice?

One mouse study found longer lives, mainly in females, and a larger program testing it at three independent labs found no lifespan gain in two tests, though in one of them the mice got less AKG than planned. Mice are not people either way, and mouse test results do not automatically transfer to humans.

Drawbacks and side effects

There is no official upper limit for AKG or established human threshold for “too much.” The six-month bone trial recorded adverse events: indigestion occurred in six women taking calcium AKG and one taking calcium alone. It was usually mild, lasted a few days and caused no withdrawals. Four women in each group withdrew because of other adverse events. The investigators considered none of the serious events treatment-related. This trial used 6 g of AKG daily; it does not establish safety for taking 1–2 g a day for years. ^[2]

The science behind calcium AKG

The evidence splits by species and by design. Worms and one strain of mice lived longer on alpha-ketoglutarate; a larger mouse program did not reproduce that. Human aging reports lack a placebo comparison, and the aging trial described below has not reported. A separate controlled trial examined bone markers and density in women with osteopenia.

Worms

A 2014 study found that alpha-ketoglutarate extended the lifespan of a laboratory worm, C. elegans, through effects on energy production and a growth-signaling pathway. A later multi-species worm screen found the effect mainly in that one species.

Mice

In a 2020 study, mice of one genetically identical laboratory strain ate chow that was 2 percent calcium AKG starting at about 18 months of age, which is middle age for a mouse. In two independently run groups of female mice:

• Median lifespan from the start of feeding rose by about 17 percent in the first group and 11 percent in the second.
• Frailty scores, based on a 31-item checklist of age-related decline, also fell.

Male survival did not change significantly. Several authors held shares in the company that later sold a calcium AKG product, and some were named on a related patent.

The US National Institute on Aging’s Interventions Testing Program tests candidate drugs in genetically mixed mice at three separate labs, to see whether a result holds across different genetic backgrounds. It fed AKG starting at 18 months to mimic the 2020 study and found no significant lifespan effect in either sex. In a follow-up reported in 2026, it started AKG at 7 months and again found no lifespan gain in males or females; the authors declared no conflicts. In that 7-month test the mice ate far less AKG than intended — measured amounts in the food were about a sixth of the target — so a higher dose was not tested.

Bone markers and bone density

A six-month randomized, double-blind trial^[2] enrolled 76 postmenopausal women with osteopenia, meaning bone density below the usual range but not necessarily osteoporosis. It compared a calcium salt supplying 6 g of AKG and 1.68 g of calcium daily with the same calcium amount given as calcium carbonate. Both were chewable tablets; this was not the 1 g timed-release aging regimen.

The published efficacy analysis included 61 women who followed the protocol. The bone-breakdown marker CTX fell more with calcium AKG at 12 and 24 weeks. Lumbar-spine bone density, however, did not differ significantly between groups: the reported between-group difference was 0.9%. The trial therefore provides a preliminary marker finding, not demonstrated fracture prevention or an anti-aging effect. Essentys sponsored the study.

People and aging

In a 2021 report, 42 customers of a saliva test company took a timed-release calcium AKG product with vitamin A (men) or vitamin D (women) for 4 to 10 months. Their average clock age was about 8 years lower than at their own start. There was no placebo group. The company used its own clock, whose estimates were about 4 years away from birthday age on average at the start, and the authors had business ties to the product. The authors themselves called for a placebo-controlled trial.

A 2026 study of 4,260 saliva-test buyers^[3] reported an association between a timed-release calcium AKG-plus-vitamin product and a lower methylation-age estimate. Among 143 people reporting that product, the abstract described an average 1.8-year lower age residual, a measure accounting for chronological age. A matched comparison gave a smaller 1.27-year difference. Other AKG products did not show a statistically clear association.

The same paper also followed repeat tests. The 26 self-reported users did not show a statistically clear improvement. In a larger subscription-based analysis involving 294 people, subscribers initially had greater odds of an improved age residual: 1.37 times the odds, with a 95% confidence interval of 1.01–1.89. That association was no longer statistically clear after adjustment for starting age residual and regression to the mean—the tendency for an unusually high or low first reading to move closer to average on repetition. Thus, the repeated measurements did not securely confirm the favorable one-time comparison.

Participants chose their own supplements and testing intervals, and some were recruited through the product maker. The senior author disclosed a scientific-adviser and board role at that company. These commercial and self-selection factors matter when interpreting the association.

The ABLE trial in Singapore randomly assigned 120 healthy adults aged 40 to 60, whose clock age was above their birthday age, to 1 g of timed-release calcium AKG or a look-alike placebo for 6 months, with a blood methylation clock as the main result and strength, body composition, and fitness as secondary results. It finished collecting its main data in August 2025. When checked on 10 October 2026, the registry’s latest update was still May 2026 and it had no posted results; our literature search found a recruitment report, but no completed efficacy paper. The trial reports Lien Foundation funding, uses a Ponce de Leon Health product, and includes an investigator who advises that company. What remains open in this aging trial is whether the tested product changes biological-age measures or physical function more than placebo.

What you may have heard on podcasts

The one podcast comment on AKG we found came from the worm stage of the research, and the National Institute on Aging’s later mouse tests did not bear it out. On 7 April 2017, on FoundMyFitness, Gordon Lithgow said alpha-ketoglutarate was “doing really well” in his group’s worm lifespan screen across several worm species, and that he was glad they could reproduce a published result. That screen was designed to pick promising candidates for the mouse testing program, and the published version found the AKG effect mainly in one worm species. When the mouse program tested AKG, it found no lifespan gain in either of its tests.

Does it improve nerve conduction?

Calcium ions help nerves pass signals and release chemical messengers; that is a normal function of calcium, described in the NIH calcium fact sheet^[4]. It does not follow that calcium AKG improves the electrical conduction of nerves. We found no human trial measuring nerve-conduction speed or showing that this supplement improves nerve function. The claim appears to carry over calcium's established role to a specific product without testing that product for the outcome.

Interpreting biological-age tests

Your body makes alpha-ketoglutarate as part of ordinary energy metabolism.

The “biological age” tests used in calcium AKG studies are DNA-methylation clocks, usually from saliva, sold by private companies. In these datasets, an individual's estimated age was about 4 to 5 years away from birthday age on average. That number does not say the clock always reads high or low, or how much a repeat result might vary, so an uncontrolled before-and-after change cannot by itself prove that a supplement reversed aging.

The bottom line

Calcium AKG remains an aging experiment rather than a proven longevity supplement. Animal findings conflict, and a younger DNA-methylation score in customers without a placebo comparison does not establish that the product reversed aging or improved health.

If you choose to take it, the unresolved benefit and limited long-term information are part of what you are paying for. It is also a poor way to choose a calcium supplement: the amount of elemental calcium and the reason for replacing it are separate questions.

Help us improve this article

Spotted an error or found a source we should consider? Tell us which part of this article needs another look and include a link if you have one. Please leave out personal health details and lab results; we can’t answer individual medical questions.

Your name

Email address

What would you like to share?Select a topicCorrectionSource or research suggestionArticle requestAccessibility issueBusiness inquirySomething else

Your message

Continue to email →Email us directly